secwatch / observer
8-K filed June 2, 2023, 7:59 PM ET ticker NERV CIK 0001598646
regulatory confidence high sentiment negative materiality 0.85

Minerva Neurosciences, Inc. (NERV): Nasdaq/NYSE listing notice — Minerva Neurosciences receives Nasdaq delisting determination; intends to request hearing

Minerva Neurosciences, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Minerva Neurosciences, Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

Exchange
nasdaq
Notice
delisting notice
Deficiency
market value
Rules
5550(b)(2)
Exact text from the filing
May 31, 2023, the Company received a second written notice from Nasdaq indicating that, based upon the Company’s continued non-compliance with the Rule, the staff of Nasdaq had determined to delist the Company’s securities from The Nasdaq Capital Market unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”). As a result, the Company intends to timely request a hearing before the Panel. The hearing request will stay any suspension or delisting action pending the completion of the hearing and the expiration of any additional extension period granted by the Pane
View on SEC.gov

Browse all listing & compliance notices →

Minerva Neurosciences, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-159827
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.